Sergey Denisenko has been promoted to Partner at Aequo in Ukraine.
Baker McKenzie has advised the shareholders of Biopharma, a Ukrainian manufacturer of pharmaceuticals and healthcare products, on the carve-out of its non-plasma business and its sale to Stada AG, a global manufacturer of pharmaceuticals and consumer healthcare products. Arzinger reportedly advised Stada on the deal.
Ukrainian commercial and residential real estate markets continue to be dynamic and are becoming more and more attractive to both local and foreign investors. The new Ukrainian Parliament, elected in summer 2019, has already passed some laws necessary for the development of the real estate sector and attracting investments to it. Below you will find an overview of the most significant changes in Ukrainian real estate legislation regarding buildings and construction in 2019.
Acting on behalf of Hemoplast PJSC, Ilyashev & Partners has persuaded Ukraine's Interdepartmental International Trade Commission to initiate a safeguard investigation into syringe imports to Ukraine regardless of the country of origin or export, which the firm says "protects the interests of all Ukrainian syringe manufacturers."